RAF-kinase inhibitor protein (RKIP) downregulation in esophageal cancer and its metastases

Clinical and Experimental Metastasis

Volumn 29, Issue 6, 2012, Pages 551-559

  Birner, Peter ^a   Jesch, Bettina ^a   Schultheis, Andrea ^b   Schoppmann, Sebastian F ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b RESEARCH INSTITUTE OF MOLECULAR PATHOLOGY   (Austria)

Author keywords

Esophageal cancer; Metastases; Raf kinase inhibitor protein; Survival

Indexed keywords

PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN;

ADULT; ARTICLE; BARRETT ESOPHAGUS; CANCER PATIENT; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISTANT METASTASIS; DOWN REGULATION; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; ESOPHAGUS DYSPLASIA; ESOPHAGUS MUCOSA; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; OVERALL SURVIVAL; PRIMARY TUMOR; PROGNOSIS; PROTEIN EXPRESSION; RETROSPECTIVE STUDY;

AGED; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LINEAR MODELS; LYMPHATIC METASTASIS; MALE; MAP KINASE SIGNALING SYSTEM; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; PROPORTIONAL HAZARDS MODELS; RECURRENCE;

EID: 84863723097     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-012-9470-8     Document Type: Article

References (25)

1. Jones PA, Takai D (2001) The role of DNA methylation in mammalian epigenetics. Science 293(5532):1068-1070
2. Bird A (2002) DNA methylation patterns and epigenetic memory. Genes Dev 16(1):6-21
3. Yoo CB, Jones PA (2006) Epigenetic therapy of cancer: past, present and future. Nat Rev Drug Discov 5(1):37-50
4. Yeung K et al (2000) Mechanism of suppression of the Raf/MEK/ extracellular signal-regulated kinase pathway by the raf kinase inhibitor protein. Mol Cell Biol 20(9):3079-3085
5. Yeung K et al (1999) Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP. Nature 401(6749):173-177
6. Al-Mulla F et al (2008) Raf kinase inhibitor protein: mechanism of loss of expression and association with genomic instability. J Clin Pathol 61(4):524-529
7. Yeung KC et al (2001) Raf kinase inhibitor protein interacts with NF-kappaB-inducing kinase and TAK1 and inhibits NF-kappaB activation. Mol Cell Biol 21(21):7207-7217
8. Ku GY, Ilson DH (2010) Esophagogastric cancer: targeted agents. Cancer Treat Rev 36(3):235-248
9. Driessen A et al (2006) Expression of carbonic anhydrase IX (CA IX), a hypoxia-related protein, rather than vascular-endothelial growth factor (VEGF), a pro-angiogenic factor, correlates with an extremely poor prognosis in esophageal and gastric adenocarci-nomas. Ann Surg 243(3):334-340
10. Tanaka N et al (2008) Expression of carbonic anhydrase 9, a potential intrinsic marker of hypoxia, is associated with poor prognosis in oesophageal squamous cell carcinoma. Br J Cancer 99(9):1468-1475
11. Beshir AB et al (2010) Raf kinase inhibitor protein suppresses nuclear factor-kappaB-dependent cancer cell invasion through negative regulation of matrix metalloproteinase expression. Cancer Lett 299(2):137-149
12. Li TT et al (2009) Beta-arrestin/Ral signaling regulates lyso-phosphatidic acid-mediated migration and invasion of human breast tumor cells. Mol Cancer Res 7(7):1064-1077
13. Li HZ et al (2009) Effects of raf kinase inhibitor protein expression on metastasis and progression of human breast cancer. Mol Cancer Res 7(6):832-840
14. Li HZ et al (2008) Effects of raf kinase inhibitor protein expression on metastasis and progression of human epithelial ovarian cancer. Mol Cancer Res 6(6):917-928
15. Schuierer MM et al (2004) Reduction in Raf kinase inhibitor protein expression is associated with increased Ras-extracellular signal-regulated kinase signaling in melanoma cell lines. Cancer Res 64(15):5186-5192
16. Chatterjee D et al (2004) RKIP sensitizes prostate and breast cancer cells to drug-induced apoptosis. J Biol Chem 279(17): 17515-17523
17. Woods Ignatoski KM et al (2008) Loss of Raf kinase inhibitory protein induces radioresistance in prostate cancer. Int J Radiat Oncol Biol Phys 72(1):153-160
18. Zaravinos A et al (2009) BRAF and RKIP are significantly decreased in cutaneous squamous cell carcinoma. Cell Cycle 8(9):1402-1408
19. Paulson TG et al (2009) Chromosomal instability and copy number alterations in Barrett's esophagus and esophageal ade-nocarcinoma. Clin Cancer Res 15(10):3305-3314
20. Ruan L et al (2010) Raf kinase inhibitor protein correlates with sensitivity of nasopharyngeal carcinoma to radiotherapy. J Cell Biochem 110(4):975-981
21. Zlobec I et al (2008) Two-marker protein profile predicts poor prognosis in patients with early rectal cancer. Br J Cancer 99(10):1712-1717
22. Minoo P et al (2007) Loss of raf-1 kinase inhibitor protein expression is associated with tumor progression and metastasis in colorectal cancer. Am J Clin Pathol 127(5):820-827
23. Hagan S et al (2005) Reduction of Raf-1 kinase inhibitor protein expression correlates with breast cancer metastasis. Clin Cancer Res 11(20):7392-7397
24. Fu Z et al (2006) Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer. Prostate 66(3):248-256
25. Chatterjee D et al (2008) Inverse association between Raf Kinase Inhibitory Protein and signal transducers and activators of transcription 3 expression in gastric adenocarcinoma patients: implications for clinical outcome. Clin Cancer Res 14(10):2994-3001